Quest Diagnostics Incorporated (DGX) Q2 2020 Earnings Results

Quest Diagnostics Beats on EPS, Stock Down 1.66%

Quest Diagnostics reported an EPS of $1.42, beating expectations slightly. However, the stock fell by 1.66% following the earnings release, indicating that investors may have been looking for stronger revenue figures or additional guidance, which was not provided.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.42	N/A	+1.07%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record for this earnings call, so the analysis is based solely on the numerical results.

Quest Diagnostics Beats on EPS, Stock Down 1.66%

Key numbers

Management commentary

Quest Diagnostics Incorporated

More earnings this week

Quest Diagnostics Beats on EPS, Stock Down 1.66%

Key numbers

Management commentary